Breast Cancer Breast
Conditions
Interventions
Following surgery to remove the tumour patients are randomised into one of six treatment groups:
1. Group A: Tamoxifen daily for 2 years
2. Group B: Tamoxifen daily until recurrence
3. Group C: Short
Sponsors
Cancer Research UK (CRUK) (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically proven adenocarcinoma of breast 2. Tumour size <5 cm 3. No clinically palpable axillary nodes 4.. Have had an operation resulting in a cosmetically satisfactory breast 5. No evidence of systemic metastases 6. No previous treatment for a malignancy by radiotherapy or chemotherapy 7. Patients with Paget's disease of the nipple, bilateral breast cancer or lymphoedema of the breast are excluded 8. No previous or co-existing malignancies, except basal cell carcinoma of skin and in-situ carcinoma of cervix 9. Patients must be fit enough to receive any of the specified treatments
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed